Join us at our inaugural event to network with fellow guests and hear from leaders in the field of medical technology discuss Building Australia from Innovation.

Event details

Date: Thursday 8 September 2022

Venue: Melbourne Museum

Title: Building Australia from Innovation

Arrive: 5.30pm for a 6.00pm start

Refreshments: served until 9.30pm

Keynote speakers

Dr Andrew Nash, Chief Scientific Officer, CSL

Panel members

To be announced


Registration is free via the link

Register today

About Dr Andrew Nash

Andrew Nash is the Chief Scientific Officer and Senior Vice President, Head of Research at CSL and is an Honorary Associate Professor at the University of Melbourne.

He completed his PhD in immunology at The University of Melbourne in 1988 and, after moving to the Centre for Animal Biotechnology in the Faculty of Veterinary Science, developed and led a research group focused on basic and applied aspects of cytokine biology.

In 1996 he joined the ASX listed biotechnology company Zenyth Therapeutics (then Amrad Corporation) as a senior scientist and subsequently held a number of positions including Director of Biologicals Research and Chief Scientific Officer. 

In July of 2005 he was appointed Chief Executive Officer of Zenyth, a position which he held up until the acquisition of Zenyth by CSL Limited in November 2006. 

Following the acquisition he was appointed as CSL’s SVP, Research and is currently based at the Bio21 Institute where he leads a large global effort focused on the discovery and development of new protein, cell and gene-based medicines to treat serious human disease.